RecruitingNot ApplicableNCT04179383

Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

Identification of Reversible Cerebral Vasoconstriction Syndrome's Precipitating Factors. Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome


Sponsor

University Hospital, Montpellier

Enrollment

225 participants

Start Date

Dec 5, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be the first to evaluate the role played by potential precipitating factors and risk factors in Reversible Cerebral Vasoconstriction Syndrome (RCVS) through of prospective selection of carefully characterised patients and controls. The impact of these factors on the prognosis will be evaluated through a follow-up assessment of patients. Our study will include the formation of a clinicoradiological database and a biobank (plasma, cerebro-spinal fluid, DNA) which will be the tools of a future large multicentre study on RCVS.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study investigates the triggers and risk factors for reversible cerebral vasoconstriction syndrome (RCVS), a condition where brain arteries suddenly and severely narrow, causing intense "thunderclap" headaches and sometimes stroke-like symptoms. The narrowing usually resolves on its own within weeks, but doctors still don't fully understand what causes it or why some people are at risk. The study compares people who have been diagnosed with RCVS against healthy volunteers and patients with non-neurological acute conditions, looking for differences in genetics, medications, lifestyle factors, and hormonal profiles that might explain why RCVS occurs. You may be eligible if (patients): - You are a man or woman aged 18 or older - You are being treated at the CHU of Montpellier - You were diagnosed with RCVS within the past 14 days - You have provided written informed consent You may be eligible if (volunteers): - You are a man or woman aged 18 or older, matched to a case patient by sex and age - You have an acute non-neurological and non-vascular condition OR are a healthy subject You may NOT be eligible if: - You are in a coma, have severe cognitive impairment, a language barrier, or severe aphasia - Follow-up for 3 months is considered impossible due to another priority condition - You are under legal protection or refuse to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERConstitution of a biobank

We are collecting additional blood and CSF samples for patients (during RCVS episode and after resolution of RCVS episode) and for control subjects to constitute a biobank, in order to compare different biologic parameters between RCVS patients and healthy volunteers. A specific agreement will be asked to patients and control subjects before collection of samples. This is why this study is classified as 'interventional' rather than 'observational'.


Locations(1)

Gui de Chauliac Hospital

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04179383